Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics®, Inc., an innovative molecular diagnostics company delivering best-in-class tests for routine genetic screening, announced that the journal Genetics in Medicine published a study online today validating the company’s powerful, proprietary next-generation DNA sequencing (NGS) approach. The study, titled “Next-Generation Carrier Screening,” demonstrates that Good Start Genetics’ DNA sequencing-based technology surpasses other methods by yielding more accurate, sensitive and complete carrier screening results. The company’s NGS-based tests are currently available to reproductive health providers across the United States as GoodStart Select™.
Help employers find you! Check out all the jobs and post your resume.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics®, Inc., an innovative molecular diagnostics company delivering best-in-class tests for routine genetic screening, announced that the journal Genetics in Medicine published a study online today validating the company’s powerful, proprietary next-generation DNA sequencing (NGS) approach. The study, titled “Next-Generation Carrier Screening,” demonstrates that Good Start Genetics’ DNA sequencing-based technology surpasses other methods by yielding more accurate, sensitive and complete carrier screening results. The company’s NGS-based tests are currently available to reproductive health providers across the United States as GoodStart Select™.
Help employers find you! Check out all the jobs and post your resume.